Lin B - Search Results

1

A seven-lncRNA signature for predicting prognosis in breast carcinoma.

Xu M, Chen Z, Lin B, Zhang S, Qu J. Xu M, et al. Among authors: lin b. Transl Cancer Res. 2021 Sep;10(9):4033-4046. doi: 10.21037/tcr-21-747. Transl Cancer Res. 2021. PMID: 35116701 Free PMC article.

2

LOC389641 promotes papillary thyroid cancer progression by regulating the EMT pathway.

Chen CZ, Wen JL, Lin BY, Zheng C, Quan RD, Zhang XH, Qu JM. Chen CZ, et al. Biomark Med. 2020 Jul;14(11):969-980. doi: 10.2217/bmm-2020-0080. Biomark Med. 2020. PMID: 32940082

3

Eva-1 homolog A promotes papillary thyroid cancer progression and epithelial-mesenchymal transition via the Hippo signalling pathway.

Lin BY, Wen JL, Zheng C, Lin LZ, Chen CZ, Qu JM. Lin BY, et al. J Cell Mol Med. 2020 Nov;24(22):13070-13080. doi: 10.1111/jcmm.15909. Epub 2020 Sep 23. J Cell Mol Med. 2020. PMID: 32969138 Free PMC article.

4

Downregulation of Immortalization-Upregulated Protein Suppresses the Progression of Breast Cancer Cell Lines by Regulating Epithelial-Mesenchymal Transition.

Wen J, Lin L, Lin B, Xia E, Qu J, Wang O. Wen J, et al. Among authors: lin b, lin l. Cancer Manag Res. 2020 Sep 18;12:8631-8642. doi: 10.2147/CMAR.S259526. eCollection 2020. Cancer Manag Res. 2020. PMID: 32982454 Free PMC article.

5

LEM domain containing 1 promotes thyroid cancer cell proliferation and migration by activating the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.

Xu M, Lin B, Zheng D, Wen J, Hu W, Li C, Zhang X, Zhang X, Qu J. Xu M, et al. Among authors: lin b. Oncol Lett. 2021 Jun;21(6):442. doi: 10.3892/ol.2021.12703. Epub 2021 Apr 2. Oncol Lett. 2021. PMID: 33868480 Free PMC article.

6

AHNAK2 Promotes the Progression of Differentiated Thyroid Cancer through PI3K/AKT Signaling Pathway.

Xu M, Wen J, Xu Q, Li H, Lin B, Bhandari A, Qu J. Xu M, et al. Among authors: lin b. Curr Cancer Drug Targets. 2024;24(2):220-229. doi: 10.2174/1568009622666220908092506. Curr Cancer Drug Targets. 2024. PMID: 36089788

7

The ETNK2 gene promotes progression of papillary thyroid carcinoma through the HIPPO pathway.

Zheng D, Jin L, Chen B, Qi Y, Bhandari A, Wen J, Lin B, Zhang X, Zhang W. Zheng D, et al. Among authors: lin b. J Cancer. 2022 Jan 1;13(2):508-516. doi: 10.7150/jca.65587. eCollection 2022. J Cancer. 2022. PMID: 35069898 Free PMC article.

8

Growth-associated protein 43 promotes thyroid cancer cell lines progression via epithelial-mesenchymal transition.

Zheng C, Quan RD, Wu CY, Hu J, Lin BY, Dong XB, Xia EJ, Bhandari A, Zhang XH, Wang OC. Zheng C, et al. J Cell Mol Med. 2019 Dec;23(12):7974-7984. doi: 10.1111/jcmm.14460. Epub 2019 Sep 30. J Cell Mol Med. 2019. PMID: 31568662 Free PMC article.

9

LRRC52-AS1 is associated with clinical progression and regulates cell migration and invasion in papillary thyroid cancer.

Zhou Y, Xiang J, Bhandari A, Wen J, Lin B, Kong L, Wang O. Zhou Y, et al. Among authors: lin b. Clin Exp Pharmacol Physiol. 2020 Apr;47(4):696-702. doi: 10.1111/1440-1681.13229. Epub 2020 Jan 22. Clin Exp Pharmacol Physiol. 2020. PMID: 31855284

10

KCNN4 is a diagnostic and prognostic biomarker that promotes papillary thyroid cancer progression.

Wen J, Lin B, Lin L, Chen Y, Wang O. Wen J, et al. Among authors: lin b, lin l. Aging (Albany NY). 2020 Aug 28;12(16):16437-16456. doi: 10.18632/aging.103710. Epub 2020 Aug 28. Aging (Albany NY). 2020. PMID: 32857728 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,902 results

Search Page

Filters